Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
For medical device manufacturers, federal preemption can be a powerful defense to state tort claims. Although there is some split of authority, most federal courts of appeals that have addressed the issue have held that when a medical device reaches the market via the Food and Drug Administration's (FDA) rigorous “premarket approval” (PMA) process, many state common law claims are expressly preempted by the Medical Device Amendments (MDA) of 1976.
The emergence of new and innovative medical products that combine FDA-regulated devices with either a drug or biologic component, however, raises the question whether manufacturers will be able to successfully assert preemption as a defense to state tort claims arising from these “combination products.” See Laura Lewis Owens and Courtney Carter Fletcher: Combination Products: Is It a Drug, Medical Device, or Biologic? (unpublished manuscript, on file with Laura Lewis Owens, Alston & Bird, LLP). Although conventional wisdom would lead many to conclude that a preemption defense should be successful for many medical device combination products, at least one federal district court decision seems to conclude that the MDA's preemption provision never applies to “combination products.”
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
On Aug. 9, 2023, Gov. Kathy Hochul introduced New York's inaugural comprehensive cybersecurity strategy. In sum, the plan aims to update government networks, bolster county-level digital defenses, and regulate critical infrastructure.
A trend analysis of the benefits and challenges of bringing back administrative, word processing and billing services to law offices.
Summary Judgment Denied Defendant in Declaratory Action by Producer of To Kill a Mockingbird Broadway Play Seeking Amateur Theatrical Rights
“Baseball arbitration” refers to the process used in Major League Baseball in which if an eligible player's representative and the club ownership cannot reach a compensation agreement through negotiation, each party enters a final submission and during a formal hearing each side — player and management — presents its case and then the designated panel of arbitrators chooses one of the salary bids with no other result being allowed. This method has become increasingly popular even beyond the sport of baseball.